These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC; Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631 [TBL] [Abstract][Full Text] [Related]
23. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Léophonte P; File T; Feldman C Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634 [TBL] [Abstract][Full Text] [Related]
24. Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. Principi N Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):669-76. PubMed ID: 8565983 [TBL] [Abstract][Full Text] [Related]
25. Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial. Lowe J; Gillespie D; Aboklaish A; Lau TMM; Consoli C; Babu M; Goddard M; Hood K; Klein N; Thomas-Jones E; Turner M; Hubbard M; Marchesi J; Berrington J; Kotecha S Lancet Respir Med; 2024 Aug; 12(8):608-618. PubMed ID: 38679042 [TBL] [Abstract][Full Text] [Related]
26. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402 [TBL] [Abstract][Full Text] [Related]
27. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial. Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759 [TBL] [Abstract][Full Text] [Related]
28. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518 [TBL] [Abstract][Full Text] [Related]
29. Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. Haworth CS; Shteinberg M; Winthrop K; Barker A; Blasi F; Dimakou K; Morgan LC; O'Donnell AE; Ringshausen FC; Sibila O; Thomson RM; Carroll KJ; Pontenani F; Castellani P; Chalmers JD; Lancet Respir Med; 2024 Oct; 12(10):787-798. PubMed ID: 39270696 [TBL] [Abstract][Full Text] [Related]
30. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764 [TBL] [Abstract][Full Text] [Related]
31. Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial. Chang AB; Morgan LC; Duncan EL; Chatfield MD; Schultz A; Leo PJ; McCallum GB; McInerney-Leo AM; McPhail SM; Zhao Y; Kruljac C; Smith-Vaughan HC; Morris PS; Marchant JM; Yerkovich ST; Cook AL; Wurzel D; Versteegh L; O'Farrell H; McElrea MS; Fletcher S; D'Antoine H; Stroil-Salama E; Robinson PJ; Grimwood K BMJ Open Respir Res; 2022 May; 9(1):. PubMed ID: 35534039 [TBL] [Abstract][Full Text] [Related]
33. Single-dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial. Morris PS; Gadil G; McCallum GB; Wilson CA; Smith-Vaughan HC; Torzillo P; Leach AJ Med J Aust; 2010 Jan; 192(1):24-9. PubMed ID: 20047544 [TBL] [Abstract][Full Text] [Related]
34. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB Trials; 2013 Sep; 14():282. PubMed ID: 24010917 [TBL] [Abstract][Full Text] [Related]
35. Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment. Goyal V; Yerkovich ST; Grimwood K; Marchant JM; Byrnes CA; Masters IB; Chang AB Chest; 2023 Dec; 164(6):1378-1386. PubMed ID: 37437879 [TBL] [Abstract][Full Text] [Related]
36. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Hoberman A; Dagan R; Leibovitz E; Rosenblut A; Johnson CE; Huff A; Bandekar R; Wynne B Pediatr Infect Dis J; 2005 Jun; 24(6):525-32. PubMed ID: 15933563 [TBL] [Abstract][Full Text] [Related]
38. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. Tapiainen T; Kujala T; Renko M; Koivunen P; Kontiokari T; Kristo A; Pokka T; Alho OP; Uhari M JAMA Pediatr; 2014 Jul; 168(7):635-41. PubMed ID: 24797294 [TBL] [Abstract][Full Text] [Related]
39. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis. Klapan I; Culig J; Oresković K; Matrapazovski M; Radosević S Am J Otolaryngol; 1999; 20(1):7-11. PubMed ID: 9950107 [TBL] [Abstract][Full Text] [Related]
40. Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial. Foster SJ; Cooper MN; Oosterhof S; Borland ML Lancet Respir Med; 2018 Feb; 6(2):97-106. PubMed ID: 29373235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]